一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> ACS Applied Nano Materials >>article
ACS Applied Nano Materials

ACS Applied Nano Materials

IF: 5.3
Download PDF

A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation

Published:1 November 2021 DOI: 10.7554/eLife.64695 PMID: 34723800
Harvey Perez,?May F Abdallah,?Jose I Chavira,?Angelina S Norris,?Martin T Egeland,?Karen L Vo,?Callan L Buechsenschuetz,?Valentina Sanghez,?Jeannie L Kim,?Molly Pind,?Kotoka Nakamura,?Geoffrey G Hicks,?Richard A Gatti,?Joaquin Madrenas,?Michelina Iacovino,?Peter J McKinnon,?Paul J Mathews

Abstract

Ataxia Telangiectasia (A-T) and Ataxia with Ocular Apraxia Type 1 (AOA1) are devastating neurological disorders caused by null mutations in the genome stability genes, A-T mutated (ATM) and Aprataxin (APTX), respectively. Our mechanistic understanding and therapeutic repertoire for treating these disorders are severely lacking, in large part due to the failure of prior animal models with similar null mutations to recapitulate the characteristic loss of motor coordination (i.e., ataxia) and associated cerebellar defects. By increasing genotoxic stress through the insertion of null mutations in both the Atm (nonsense) and Aptx (knockout) genes in the same animal, we have generated a novel mouse model that for the first time develops a progressively severe ataxic phenotype associated with atrophy of the cerebellar molecular layer. We find biophysical properties of cerebellar Purkinje neurons (PNs) are significantly perturbed (e.g., reduced membrane capacitance, lower action potential [AP] thresholds, etc.), while properties of synaptic inputs remain largely unchanged. These perturbations significantly alter PN neural activity, including a progressive reduction in spontaneous AP firing frequency that correlates with both cerebellar atrophy and ataxia over the animal's first year of life. Double mutant mice also exhibit a high predisposition to developing cancer (thymomas) and immune abnormalities (impaired early thymocyte development and T-cell maturation), symptoms characteristic of A-T. Finally, by inserting a clinically relevant nonsense-type null mutation in Atm, we demonstrate that Small Molecule Read-Through (SMRT) compounds can restore ATM production, indicating their potential as a future A-T therapeutic.

Substances (4)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
GJ103 1459687-89-8 C16H14N4O3S 51 suppliers Inquiry
GJ103 1459687-89-8 C16H14N4O3S 51 suppliers Inquiry

Similar articles

莱芜市| 台东县| 长子县| 天峨县| 宁夏| 南雄市| 汝州市| 海口市| 年辖:市辖区| 奎屯市| 屯留县| 瓮安县| 长岭县| 玛纳斯县| 民和| 梅州市| 普宁市| 马公市| 武乡县| 琼结县| 太和县| 沂源县| 龙陵县| 新和县| 三都| 龙山县| 凤凰县| 屏山县| 芜湖县| 平湖市| 胶州市| 海盐县| 会同县| 龙山县| 博野县| 荆州市| 巴林右旗| 泾阳县| 察隅县| 昌邑市| 东安县|